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Abstract 
Activated microglia are considered to play important roles in degenerative processes of 
midbrain dopaminergic neurons.  Here we examined mechanisms of neurotoxicity of 
thrombin, a protease known to trigger microglial activation, in organotypic midbrain slice 
cultures.  Thrombin induced a progressive decline in the number of dopaminergic neurons, 
an increase in nitric oxide (NO) production, and whole tissue injury indicated by lactate 
dehydrogenase release and propidium iodide uptake.  Microglia expressed inducible NO 
synthase (iNOS) in response to thrombin, and inhibiton of iNOS rescued dopaminergic 
neurons without affecting whole tissue injury.  Inhibitors of mitogen-activated protein 
kinases (MAPKs) such as ERK, p38 MAPK and JNK attenuated thrombin-induced iNOS 
induction and dopaminergic cell death.  Whole tissue injury was also attenuated by 
inhibition of ERK and p38 MAPK.  Moreover, depletion of resident microglia from 
midbrain slices abrogated thrombin-induced NO production and dopaminergic cell death, but 
did not inhibit tissue injury.  Finally, antioxidative drugs prevented thrombin-induced 
dopaminergic cell death without affecting whole tissue injury.  Hence, NO production 
resulting from MAPK-dependent microglial iNOS induction is a crucial event in 
thrombin-induced dopaminergic neurodegeneration, whereas damage of other midbrain cells 
is MAPK-dependent but is NO-independent. 
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Brain inflammatory reactions are characterized by activation of glial cells such as astrocytes 
and microglia.  Particularly, microglia respond to various types of brain injury including 
trauma, ischemia and hemorrhage, and appear to act as guard cells by removing the debris of 
injured cells and promoting neurite regeneration (Kreutzberg 1996).  On the other hand, 
aberrant microglial activation may be harmful to surviving neurons (Stoll an Jander 1999), 
because activated microglia can produce diverse sets of diffusible cytotoxic factors, namely, 
cytokines/chemokines, reactive oxygen species and nitric oxide (NO). 
 Local inflammatory reactions are observed in various neurodegenerative disorders 
including Alzheimer’s disease and Parkinson’s disease (PD).  In PD, selective degeneration 
of dopaminergic neurons is accompanied by accumulation of a large number of reactive 
microglia in the substantia nigra (McGeer et al. 1988; Hirsch et al. 1998).  Inflammatory 
reactions around degenerating dopaminergic neurons are also found in experimental models 
of PD such as MPTP-treated mice and monkeys (Kurkowska-Jastrzebska et al. 1999; McGeer 
et al. 2003).  Several lines of evidence suggest that expression of inducible NO synthase 
(iNOS) in microglia and a resultant increase in NO production are involved in degeneration of 
dopaminergic neurons.  In fact, iNOS expression is increased in microglia in the substantia 
nigra of PD patients (Knott et al. 2000).  Mice lacking iNOS gene are resistant to MPTP 
toxicity (Liberatore et al. 1999), and pharmacological inhibition of iNOS in vivo rescues 
dopaminergic neurons from lipopolysaccharide-induced degeneration in rats (Iravani et al. 
2002).  In this context, we have demonstrated in organotypic midbrain slice cultures that NO 
derived from microglial iNOS plays a crucial role in degeneration of dopaminergic neurons 
induced by interferon-γ and lipopolysaccharide (Shibata et al. 2003).  Peroxynitrite anion 
(ONOO−) formed by reaction of NO with superoxide anion is generally considered to be 
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responsible for NO cytotoxicity, because ONOO− can produce hydroxyl radical, an extremely 
reactive species (Lipton et al. 1993). 
 In the present study we focused on thrombin.  This serine protease, well known to play a 
pivotal role in blood coagulation cascade, may also act as a signaling molecule in the brain 
(Xie et al. 2003).  Protease-activated receptors that mediate biological actions of thrombin 
are distributed widely throughout the central nervous system, and are expressed in neurons, 
astrocytes and microglia (Noobakhsh et al. 2003).  One of the established actions of 
thrombin on brain cells is the ability to activate microglia, which is accompanied by induction 
of iNOS (Ryu et al. 2000; Suo et al. 2002).  When injected into the substantia nigra in vivo, 
thrombin causes degeneration of dopaminergic neurons, which appears to be mediated by 
activation of microglia (Carreno-Muller et al. 2003; Choi et al. 2003a), and a non-selective 
NOS inhibitor partially inhibits thrombin-induced dopaminergic neurodegeneration in vivo 
(Choi et al. 2003a).  On the other hand, thrombin can induce dopaminergic cell death in 
dissociated midbrain cultures devoid of microglia, suggesting possible direct actions of 
thrombin onto neurons (Choi et al. 2003b).  Direct cytotoxic actions of thrombin have also 
been described in cultured hippocampal neurons (Donovan et al. 1997; Suo et al. 2003).  
Here, using midbrain slice cultures, we investigated whether microglial activation is a crucial 
step for induction of dopaminergic cell death by thrombin.  Organotypic slice cultures 
maintain tissue architecture observed in vivo, thus are suitable for examinations of the 
mechanisms of neurodegeneration involving cell-to-cell interactions.  In this study, particular 
attention was paid to the roles of iNOS induction, and also to the potential involvement of 
mitogen-activated protein kinases (MAPKs).  MAPKs such as extracellular signal-regulated 
kinase (ERK), p38 MAPK and c-Jun N-terminal kinase (JNK) are known to regulate cell 
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survival and death under various conditions (Davis 2000; Gallo and Johnson 2002; 
Colucci-D’Amato et al. 2003).  Several members of MAPK family have been reported to 
mediate biological responses to thrombin, including microglial activation (Ryu et al. 2000) 
and neuronal death (Choi et al. 2003a; Suo et al. 2003). 
 
 
Materials and Methods 
Culture preparation 
Organotypic midbrain slice cultures were prepared according to the methods described 
previously (Shibata et al. 2003).  All procedures were approved by our institutional animal 
experimentation committee, and animals were treated in accordance with the Guidelines of 
the United States National Institutes of Health regarding the care and use of animals for 
experimental procedures.  Briefly, postnatal 2 - 3 day-old Wistar rats (Nihon SLC, Shizuoka, 
Japan) were anesthetized by hypothermia and were decapitated, the brain was removed from 
the skull and separated into two hemispheres.  Coronal midbrain slices (350 μm thick) were 
prepared under sterile conditions and transferred onto microporous membranes (Millicell-CM, 
Millipore, Bedford, MA, U.S.A.) in 6-well plates.  Six slices from one hemisphere were 
placed together in one membrane.  Culture medium, consisting of 50% minimal essential 
medium/HEPES, 25% Hanks’ balanced salt solution and 25% heat-inactivated horse serum 
(Invitrogen Japan, Tokyo, Japan) supplemented with 6.5 mg/ml glucose, 2 mM L-glutamine 
and 10 U/ml penicillin-G / 10 μg/ml streptomycin, was supplied at a volume of 0.76 ml per 
each well.  The culture medium was exchanged with fresh medium on the next day of 
culture preparation, and thereafter, every two days.  Slices were maintained in a 34°C, 5% 
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CO2 humidified atmosphere. 
 
Drug treatment 
At 16 - 17 days in vitro, slices were exposed to thrombin (T4648, Sigma-Aldrich Chemicals, 
St. Louis, MO, USA) and other drugs, by transfer of culture inserts to culture plates filled 
with 0.76 ml of drug-containing serum-free medium.  Serum-free medium consisted of 75% 
minimal essential medium/HEPES and 25% Hanks’ balanced salt solution supplemented with 
6.5 mg/ml glucose, 2 mM L-glutamine and 10 U/ml penicillin-G / 10 μg/ml streptomycin.  
Aminoguanidine and clodronate were purchased from Sigma-Aldrich Chemicals.  1400W, 
PD98059, SB203580 and 5,10,15,20-tetrakis-(4-sulfonatophenyl)-porphyrinato-iron(III) 
chloride (FeTPPS) were from Calbiochem (San Diego, CA, USA).  SP600125 and 
Nω-propyl-L-arginine were obtained from Tocris Cookson (Bristol, UK).  N-acetylcysteine 
was from Nacalai Tesque (Kyoto, Japan). 
 
Immunohistochemistry 
After drug treatment, cultures were fixed with 4% paraformaldehyde in 0.1 M phosphate 
buffer containing 4% sucrose for 2 h, and whole slice cultures without sectioning were 
processed for tyrosine hydroxylase (TH) immunohistochemistry as described (Shibata et al. 
2003).  We used rabbit anti-TH polyclonal antibody (1:500, AB-152, Chemicon International, 
Temecula, CA, USA) as the primary antibody, and biotinylated anti-rabbit IgG from goat 
(1:200, Vector Lab., Burlingame, CA, USA) as the secondary antibody.  After incubation 
with the secondary antibody, cultures were treated with avidin-biotinylated horseradish 
peroxidase complex (Vectastain Elite ABC kit, Vector Lab.), and then peroxidase was 
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visualized with 0.07% diaminobenzidine and 0.018% H2O2.  Specimens were dehydrated 
and mounted on slide glasses.  Positively stained cells bearing developed dendrites that were 
at least more than twice as long as cell diameter were considered as viable dopaminergic 
neurons.  The maximal number of viable dopaminergic neurons in an area of 520 × 670 μm2 
in individual slices was counted.  Although TH-positive neurons existed as several layers of 
cell population, we could count the number of these neurons in a fixed area by slightly 
moving the focus of the microscope on the cultures along z-axis.  We also performed 
glutamic acid decarboxylase (GAD) immunohistochemistry to identify GABAergic neurons.  
Procedures for GAD immunohistochemistry were the same as those for TH 
immunohistochemistry, except that rabbit anti-GAD65/67 polyclonal antibody (1:500; AB1511, 
Chemicon) was used as the primary antibody.  The number of GAD-positive neurons in an 
area of 520 × 670 μm2 in individual slices was counted.  Additionally, total number of 
neurons was estimated by immunohistochemistry for a neuronal marker NeuN, with the use of 
mouse anti-NeuN monoclonal antibody (1:500, Chemicon) as the primary antibody and 
biotinylated anti-mouse IgG from horse (1:200, Vector Lab.) as the secondary antibody. 
 For confirmation of microglial depletion (see below), immunohistochemical examinations 
were performed on OX42, a marker of microglia.  In this case, the primary antibody was 
mouse anti-OX42 (1:200, Serotec Ltd., Oxford, UK), and biotinylated anti-mouse IgG from 
horse (1:200, Vector Lab.) was used as the secondary antibody.  Other procedures were the 
same as those for TH immunohistochemistry. 
 In several experiments, double immunofluorescence histochemistry was done for OX42 
with iNOS, phospho-ERK or phospho-JNK.  Primary antibodies for detection of iNOS, 
phospho-ERK and phospho-JNK were rabbit anti-iNOS (1:200, BD Transduction Lab., San 
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Diego, CA, USA), rabbit anti-phospho-p44/42 MAP kinase (T202/Y204) (1:200, Cell 
Signaling Technology, Beverly, MA, USA) and rabbit anti-phospho-JNK (1:200, Cell 
Signaling Technology), respectively.  Alexa Fluor 488-labeled goat anti-mouse IgG (1:1000, 
Molecular Probes, Eugene, OR, USA) and Alexa Fluor 568-labeled goat anti-rabbit IgG 
(1:1000, Molecular Probes) were used as secondary antibodies. 
 
Nitrite quantification 
Amount of NO released during thrombin treatment was quantified as concentrations of nitrite 
in culture medium by Griess method.  One hundred μl of culture supernatants was collected 
and reacted with an equal volume of Griess reagent (1% sulfanilamide and 0.1% 
N-(1-naphthyl)-ethylenediamine dihydrochloride in 2.5% phosphoric acid) for 10 min at room 
temperature, and absorbance of diazonium compound was measured at 540 nm.  Absolute 
levels of nitrite were determined with reference to a standard curve obtained from defined 
concentrations of sodium nitrite. 
 
Lactate dehydrogenase release assay 
Amount of lactate dehydrogenase (LDH) released into culture medium after thrombin 
treatment was determined by a Cytotoxicity Detection LDH kit (Kyokuto Pharmaceutical 
Industrial Corp., Tokyo, Japan).  In this assay, NAD is reduced to NADH through the 
conversion of lactate to pyruvate by LDH, and NADH reduces tetrazolium into formazan dyes 
in the presence of diaphorase.  Twenty-five μl of culture supernatants was collected and 
incubated with 75 μl of coloring reagent in a 96-well plate at room temperature.  After 
incubation for 1 h, the reaction was stopped by addition of 100 μl of 1 M HCl, and the 
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absorbance at 570 nm was determined with the use of a microplate reader.  Values were 
normalized with the amount of LDH released from a separate group of slices (of the same 
sister culture) that received 300 μM MPP+ for 72 h as 100%.  This concentration of MPP+ 
caused cell damage non-specifically. 
 
Propidium iodide uptake 
In addition to LDH release, propidium iodide (PI) uptake was used for assessment of overall 
injury of slice cultures (Fujimoto et al. 2004).  PI (Wako Pure Chemicals, Osaka, Japan) was 
applied at 5 μg/ml during drug treatment, and the fluorescence in slices was observed through 
an inverted fluorescence microscope with a rhodamine filter set.  In experiments with 
FeTPPS, slices were incubated for 3 h with serum-free medium containing 5 μg/ml PI after 
drug treatment, then PI fluorescence was observed.  Fluorescence images were captured 
through a monochrome chilled CCD camera (C5985, Hamamatsu Photonics, Hamamatsu, 
Japan), and stored images were analyzed with NIH image 1.62 software.  The signal 
intensity of each pixel was expressed as an 8-bit value, and the averaged intensity in an area 
of 180 × 180 μm2 was obtained as the fluorescence value of each slice.  Fluorescence values 
were normalized with the intensity of fluorescence in a separate group of slice cultures that 
received 300 μM MPP+ for 72 h as 100%. 
 
Western blotting 
After treatment with thrombin and drugs for indicated periods, slices were collected in buffer 
containing 20 mM Tris-HCl (pH 7.0), 25 mM β-glycerophosphate, 2 mM EGTA, 1% Triton 
X-100, 1 mM phenylmethylsulfonyl fluoride, 1% aprotinin, 2 mM dithiothreitol and 1 mM 
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vanadate, and homogenized on ice.  Lysates were centrifuged at 15000 g at 4°C for 30 min 
and the protein concentration in each sample was determined with a Bio-Rad Protein Assay 
kit.  Sample buffer containing 124 mM Tris-HCl, 4% sodium dodecyl sulfate (SDS), 4% 
2-mercaptoethanol, 10% glycerol and 0.02% bromophenol blue was added to each sample, 
and heated at 90°C for 5 min.  SDS-polyacrylamide gel electrophoresis was performed on a 
10% running gel with a 3% stacking gel.  After gel electrophoresis, proteins were transferred 
onto polyvinylidene difluoride membranes.  The blots were washed with Tris-buffered saline 
containing 0.1% Tween 20 and blocked with 5% skimmed milk for 1 h.  The membrane was 
incubated with mouse anti-iNOS antibody (1:1000, BD Transduction Lab.), mouse 
anti-phospho-p44/42 MAP kinase (T202/Y204) (1:1000, Cell Signaling Technology), rabbit 
anti-phospho-p38 MAP kinase (Thr180/Tyr182) (1:1000, Cell Signaling Technology), rabbit 
anti-p38 (1:1000, Santa Cruz Biotech., Santa Cruz, CA, USA), mouse anti-phospho-JNK 
(1:1000, Santa Cruz Biotech.), goat anti-actin(C-11) (1:10000, Santa Cruz Biotech.) and 
mouse anti-glyceraldehyde phosphate dehydrogenase antibody (1:10000, Ambion, Austin, TX, 
USA), overnight at 4°C.  After incubation with horseradish peroxidase-conjugated secondary 
antibodies (Vector Lab.) at room temperature for 1 h, bands were detected with enhanced 
chemiluminescence detection system (Amersham Biosciences, Piscataway, NJ, USA) and 
exposed to Fuji X-ray film.  Band intensities were analyzed with NIH image. 
 
Microglial depletion by clodronate-containing liposomes 
Liposomes containing phosphate-buffered saline or clodronate were prepared according to the 
methods described by Van Rooijen and Sanders (1994) and were applied to slice cultures for 
24 h by addition of final liposome suspension at indicated volumes in 0.76 ml of culture 
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medium.  Liposomes containing clodronate are selectively taken up by phagocytic cells, 
where clodronate exerts cytotoxicity.  Successful depletion of microglia by this method has 
been reported in cultured rat cerebellar slices (Martin-Teva et al. 2004).  Depletion of 
microglia was confirmed by OX42 immunohistochemistry as described above. 
 
Statistical analysis 
Results are expressed as means ± SEM.  Statistical significance was evaluated with one-way 
ANOVA followed by Student-Newman-Keuls’ test, and probability values less than 5% were 
considered significant. 
 
 
Results 
Thrombin induces dopaminergic cell death, NO production and whole tissue injury 
Application of 300 U/ml thrombin to midbrain slice cultures for 72 h induced a marked 
decrease in the number of viable dopaminergic neurons.  Dopaminergic neurons surviving 
after thrombin treatment also exhibited degeneration and atrophy of dendritic processes and 
shrinkage of cell bodies (Fig. 1a and b).  The neurotoxic effect of thrombin on dopaminergic 
neurons was in a concentration-dependent manner, reaching a statistically significant level at 
all tested concentrations of 100 - 500 U/ml (Fig. 1c).  In addition, thrombin increased nitrite 
levels in culture medium in a concentration-dependent manner, which reflected increase in 
NO production (Fig. 1d).  To assess whether thrombin induces whole tissue injury, we 
examined amount of LDH released into culture medium.  Because dopaminergic neurons 
comprise only a small subset of midbrain cells located in a confined area within the midbrain, 
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levels of LDH release essentially reflect cytotoxic damage of other cells within midbrain 
tissues (Shibata et al. 2003).  Indeed, we examined total number of TH-immunoreactive cells 
and NeuN-immunoreactive cells in midbrain slices cultured under control conditions, and the 
percentage of TH-positive neurons was estimated to be 2.8% of all neurons in our slice 
cultures.  We also determined the levels of PI uptake as an alternative method to evaluate 
whole tissue injury.  Thrombin treatment increased LDH release into medium and PI uptake 
into tissues in a concentration-dependent manner (Fig. 1e, f).  The effect of thrombin on 
these parameters reached statistical significance at 300 and 500 U/ml.  The number of 
GABAergic neurons assessed by GAD immunohistochemistry also decreased in response to 
thrombin at concentrations of 300 and 500 U/ml (Fig. 1g). 
 We next examined time course of the effects of thrombin.  A significant decrease in the 
number of dopaminergic neurons was detected already at 24 h after application of 300 U/ml 
thrombin, but the decrease was progressively evident during 72 h of thrombin treatment (Fig. 
2a).  Increase in nitrite concentrations exhibited a similar time-dependent change, reaching 
statistical significance at 48 and 72 h of thrombin treatment (Fig. 2b).  On the other hand, the 
increase in the amount of LDH released into culture medium (Fig. 2c) and the decrease in the 
number of GABAergic neurons (Fig. 2d) showed a delayed pattern, reaching a significant 
level after 72 h. 
 Overall, these results indicate that thrombin induces dopaminergic cell death, NO 
production and whole tissue injury.  In the following experiments, treatment with 300 U/ml 
thrombin for 72 h was employed as the standard procedure to evaluate thrombin cytotoxicity. 
 
iNOS-derived NO mediates thrombin cytotoxicity on dopaminergic neurons but not on 
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other midbrain cells 
To examine potential involvement of iNOS in thrombin cytotoxicity, we performed double 
immunofluorescence staining against iNOS and OX42, a microglial marker, on midbrain slice 
cultures treated with 300 U/ml thrombin for 72 h.  iNOS immunoreactivity overlapped with 
a subset of OX42-immunoreactive cells, indicating expression of iNOS in microglia (Fig. 3a). 
 We next examined the effect of aminoguanidine, a drug that preferentially blocks the 
activity of iNOS among NOS isoforms.  Concurrent application of aminoguanidine (100 - 
500 μM) with thrombin markedly attenuated nitrite accumulation in medium (Fig. 3c).  
Dopaminergic cell death induced by thrombin was also inhibited by the same concentrations 
of aminoguanidine (Fig. 3b).  In contrast, aminoguanidine did not provide a significant 
protective effect against thrombin-induced whole tissue injury, as assessed by LDH release 
(Fig. 3d) and PI uptake (Fig. 3e).  Similar results were obtained when thrombin was applied 
concurrently with 1400W (30 and 100 μM), another selective inhibitor of iNOS (data not 
shown).  Nω-propyl-L-arginine (30 and 100 μM), a neuronal NOS-selective inhibitor, showed 
no effect on thrombin-induced dopaminergic cell death, nitrite production and whole tissue 
injury (data not shown). 
 
MAPKs are involved in thrombin-induced cell death and NO production 
We examined consequences of inhibition of MAPKs on thrombin actions in midbrain slice 
cultures.  PD98059 (10 - 100 μM), a drug that compromises ERK activation by inhibiting 
mitogen/extracellular signal-regulated kinase, prevented thrombin-induced dopaminergic cell 
death (Fig. 4a).  Thrombin-induced nitrite accumulation was partially but significantly 
inhibited by PD98059 (Fig. 4b).  Notably, PD98059 also markedly attenuated 
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thrombin-induced whole tissue injury as assessed by LDH release (Fig. 4c) and PI uptake 
(data not shown).  SB203580 (3 - 30 μM), an inhibitor of p38 MAPK, provided similar 
effects to those of PD98059: this drug potently inhibited thrombin-induced dopaminergic cell 
death, nitrite accumulation and whole tissue injury (Fig. 4d-f).  Inhibition of nitrite 
accumulation by 10 - 30 μM of SB203580 was almost complete (Fig. 4e), in contrast to 
partial inhibition by PD98059.  We also found that SP600125 (10 - 100 μM), a JNK inhibitor, 
blocked thrombin-induced dopaminergic cell death and nitrite accumulation in a 
concentration-dependent manner (Fig. 4g, h).  Effect of SP600125 on thrombin-induced 
whole tissue injury was not obvious, partly because the drug stimulated LDH release by itself 
(Fig. 4i).  Taken together, these results suggest that all major classes of MAPKs are involved 
in dopaminergic cell death and NO production induced by thrombin, and that ERK and p38 
are also involved in thrombin-induced death of other midbrain cells. 
 
MAPKs are involved in thrombin-induced iNOS expression 
Effective blockade of nitrite production by MAPK inhibitors suggests that these MAPKs 
regulate expression of iNOS induced by thrombin.  We therefore examined the relationship 
between iNOS expression and MAPK activation by western blot analysis and 
immunohistochemical examinations.  iNOS expression started to increase at 12 h after the 
onset of thrombin application, and reached a plateau level at 24 h (Fig. 5a, e).  Western blot 
with antibodies specific for phosphorylated forms of MAPKs revealed that activation of 
MAPKs preceded iNOS expression (Fig. 5a, d).  The phosphorylated levels of all MAPKs 
increased as early as 30 min after application of thrombin.  Maximal increases of 
phospho-ERK (4.7 fold) and phospho-JNK (2.1 fold) were observed at 3 h, and then the levels 
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of these phopho-MAPKs gradually declined to the control level.  Phospho-p38 increased 6.4 
fold at 30 min after administration of thrombin, and the elevated level persisted for 72 h (Fig. 
5d).  Immunofluorescence staining of OX42 combined with staining of phosho-ERK or 
phospho-JNK showed that intense activation of ERK and JNK occurred in microglia in slices 
treated with thrombin for 1 h (Fig. 5b, c). 
 Next we tested the effects of inhibitors of MAPKs on thrombin-induced iNOS expression 
(Fig. 5f).  SB203580 (30 μM) concomitantly applied with thrombin almost completely 
blocked iNOS expression assessed at 72 h after thrombin application.  PD98059 (100 μM) 
and SP600125 (30 μM) also significantly suppressed thrombin-induced iNOS expression. 
 
Depletion of microglia protects dopaminergic neurons from thrombin cytotoxicity 
Results so far indicated that microglial activation and iNOS expression is a crucial step for 
induction of dopaminergic cell death by thrombin.  To substantiate this proposal, we 
depleted microglia from slice cultures by a method developed for macrophage depletion (Van 
Rooijen and Sanders 1994).  Immunohistochemisitry against OX42 showed that robust 
increase in activated microglia induced by 72-h treatment with 300 U/ml thrombin was 
largely attenuated by 24-h pretreatment with clodronate-containing liposomes (Fig. 6a-d).  
At the same time, thrombin-induced dopaminergic cell death and nitrite accumulation were 
also abrogated (Fig. 6e, f).  Amount of thrombin-induced LDH release was not significantly 
affected by pretreatment with clodronate-containing liposomes (Fig. 6g).  As a control, 
liposomes containing phosphate-buffered saline showed no effect on dopaminergic cell death, 
nitrite accumulation and LDH release (data not shown).  These results further indicate that 
microglia is essential for thrombin-induced dopaminergic cell death. 
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 Antioxidative drugs protect dopaminergic neurons but not other midbrain cells from 
thrombin cytotoxicity 
Finally, we examined effects of drugs that inhibit oxidative stress on thrombin cytotoxicity, to 
delineate the mechanisms of NO-dependent dopaminergic cell death.  To determine whether 
ONOO− is involved in thrombin-induced dopaminergic cell death, we examined the effect of 
an ONOO− scavenger, FeTPPS.  As shown in Fig. 7a and b, FeTPPS (30 and 100 μM) 
significantly inhibited thrombin-induced dopaminergic cell death but had not effect on whole 
tissue injury as assessed by PI uptake.  Nitrite concentration and LDH release could not be 
examined because the color of FeTPPS itself interfered the assay.  We also examined the 
effect of an antioxidant N-acetylcysteine.  Concurrent application of N-acetylcysteine (0.3 - 
3 mM) protected dopaminergic neurons from thrombin cytotoxicity in a 
concentration-dependent manner (Fig. 7c), whereas the drug did not affect nitrite 
accumulation (Fig. 7d) and whole tissue injury (Fig. 7e, f).  These results indicate that 
ONOO−-related reactive oxygen species play an important role in thrombin-induced 
dopaminergic cell death, although they made little contribution to injury of other midbrain 
cells. 
 
 
Discussion 
Prothrombin and protease-activated receptors are widely distributed in the central nervous 
system, and thrombin elicits a variety of biological responses in neurons and glial cells 
(Noobakhsh et al. 2003).  Thus, thrombin-mediated signaling may play important roles in 
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physiological and pathological processes in the brain.  Microinjection of thrombin into the 
substantia nigra of rats causes degeneration of dopaminergic neurons, in addition to local 
inflammatory reactions involving microglial activation (Carreno-Muller et al. 2003; Choi et al. 
2003a, 2003b).  These pathological changes are reminiscent of those observed in PD, where 
selective degeneration of dopaminergic neurons is accompanied by inflammatory reactions 
(Herrera et al. 2005).  Although relationship between thrombin dysregulation and PD 
pathogenesis remains to be established, elucidation of the mechanisms of thrombin 
neurotoxicity may provide an important clue to understand degenerative processes of 
dopaminergic neurons. 
 We demonstrated that thrombin induced cell death in midbrain slice cultures.  
Comparison of the changes in the number of dopaminergic neurons, the amount of LDH 
release and the number of GABAergic neurons suggests that thrombin cytotoxicity exhibits 
some selectivity on dopaminergic neurons, because lower concentrations and shorter periods 
of application were sufficient for thrombin to induce dopaminergic cell death than those to 
induce whole tissue injury or GABAergic neuron loss.  In our slice cultures, percentage of 
dopaminergic neurons was estimated to be less than 3 % of all neurons.  Thus, although 
degeneration of dopaminergic neurons should be accompanied by LDH release, the amount of 
LDH released from these neurons makes little contribution to the total amount of LDH that 
reflects whole tissue injury.  Concerning the selectivity, an in vivo study by Carreno-Muller 
et al. (2003) suggested that GABAergic neurons were not affected by thrombin, which is 
consistent with our observations.  On the other hand, Choi et al. (2003b) and Lee et al. 
(2005) did not find selectivity of thrombin toxicity on dopaminergic neurons over other cell 
populations in vivo and in dissociated mesencephalic culture, respectively.  We do not have 
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obvious explanations for this discrepany, but an interesting point that should be considered is 
a difference in rat strains.  That is, Choi et al. (2003b) and Lee et al. (2005) used 
Sprague-Dawley rats, whereas Carreno-Muller et al. (2003) and we (this study) used Wistar 
rats.  How the strain difference could affect selectivity of thrombin cytotoxicity is totally 
unknown, but this situation is reminiscent of the different sensitivity of dopaminergic neurons 
to MPTP between mice and rats (Giovanni et al. 1994) and among different mouse strains 
(Hamre et al. 1999).  In this study, we chose a condition of thrombin application (300 U/ml 
for 72 h) that caused both robust dopaminergic cell death and whole tissue injury, to examine 
whether different mechanisms were involved in degeneration of different cell populations. 
 We particularly focused on the involvement of iNOS in thrombin cytotoxicity, because 
this inducible enzyme seems to play an important role in dopaminergic neurodegeneration in 
several experimental models and in PD brain (Liberatore et al. 1999; Knott et al. 2000).  
Consistent with the ability of thrombin to induce expression of iNOS (Ryu et al. 2000; Suo et 
al. 2002; Carreno-Muller et al. 2003; Choi et al. 2003a), we found that thrombin triggered 
induction of iNOS in microglia within midbrain slice cultures, which was accompanied by 
increased NO production.  Removal of microglia by pretreatment with clodronate-containing 
liposomes resulted in a marked decrease in nitrite levels, confirming that iNOS-expressing 
microglia are responsible for NO production in response to thrombin.  Moreover, effects of 
iNOS inhibitors and microglial depletion indicate that NO derived from microglial iNOS is 
instrumental to thrombin-induced dopaminergic cell death.  Interestingly, NO does not 
contribute to thrombin-induced degeneration of other midbrain cells, because abolition of NO 
production by iNOS inhibitors or by depletion of microglia did not prevent whole tissue injury.  
This is in contrast to the case with microglial activation induced by interferon-γ and 
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lipopolysaccharide, where inhibition of iNOS abrogated whole tissue injury in addition to 
dopaminergic cell death (Shibata et al. 2003).  Nevertheless, effective protection of 
dopaminergic neurons by iNOS inhibition in both models of microglial activation highlights 
NO as a key molecule regulating dopaminergic neurodegeneration under inflammatory 
conditions. 
 Concerning MAPK family, ERK and p38 are implicated in thrombin-induced iNOS 
expression in cultured microglia (Ryu et al. 2000) and in the substantia nigra in vivo (Choi et 
al. 2003a).  In addition, inhibition of ERK and p38 provided significant protection of nigral 
dopaminergic neurons against thrombin cytotoxicity in vivo (Choi et al. 2003a).  A recent 
study on dissociated midbrain cultures demonstrated that inhibition of p38 and JNK 
attenuated thrombin cytotoxicity on dopaminergic neurons (Lee et al. 2005).  In the present 
study, we extended these lines of evidence by showing that JNK, in addition to ERK and p38, 
is involved in thrombin-induced microglial iNOS expression in midbrain tissues.  We also 
showed that all of these MAPKs mediate thrombin-induced dopaminergic neurodegeneration, 
at least in part through induction of iNOS expression and NO production.  Notably, 
PD98059 and SB203580 potently inhibited whole tissue injury, indicating that MAPKs such 
as ERK and p38 also mediate thrombin-induced injury of cells other than dopaminergic 
neurons.  However, MAPK-dependent iNOS expression does not participate in this process 
because, as mentioned above, iNOS inhibition did not suppress whole tissue injury.  
Although precise mechanisms of degeneration of other midbrain cells remain to be 
determined, thrombin has been reported to exert cytotoxicity directly on cultured hippocampal 
neurons and astrocytes (Donovan et al. 1997).  Moreover, ERK activation is implicated in 
thrombin cytotoxicity in a hippocampal neuronal cell line (Suo et al. 2003).  Indeed, we 
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observed that PD98059 potently inhibited thrombin-induced dopaminergic cell death in spite 
of partial blockade of NO production.  These results propose that ERK in cells other than 
microglia, possibly dopaminergic neurons themselves, may also be involved in induction of 
cell death.  This possibility deserves further investigations. 
 We further suggest that oxidative stress is involved in thrombin-induced dopaminergic cell 
death.  This is based on the observations that both an ONOO− scavenger FeTPPS and an 
antioxidant N-acetylcysteine protected dopaminergic neurons from thrombin cytotoxicity.  
Hence, NO-induced dopaminergic cell death is likely to be mediated by generation of ONOO− 
from the reaction of NO and superoxide anion.  In this study we did not address the sources 
of superoxide, but a recent study showed that microinjection of thrombin into the 
hippocampus induced upregulation of NADPH oxidase, an enzyme well known to produce 
superoxide (Choi et al. 2005).  Whether NADPH oxidase is involved in thrombin-induced 
dopaminergic cell death is an interesting issue to be investigated.  FeTPPS and 
N-acetylcysteine did not prevent whole tissue injury induced by thrombin, which supports the 
idea that NO-related reactive species do not participate in degeneration of other midbrain 
cells. 
 Overall, we for the first time demonstrated that thrombin recruits different mechanisms to 
exert cytotoxicity onto dopaminergic neurons than those onto other midbrain cells.  
Thrombin activates multiple members of MAPKs such as ERK, p38 MAPK and JNK.  
These MAPKs are involved in expression of iNOS in microglia, which causes robust 
increases in NO production.  NO plays a critical role in degeneration of dopaminergic 
neurons through the conversion to ONOO−.  On the other hand, in spite of its dependency on 
MAPK activation, degeneration of other midbrain cells occurs independently of 
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microglia-derived NO.  Different mechanisms of thrombin cytotoxicity between 
dopaminergic neurons and other midbrain cells may reflect the fact that dopaminergic neurons 
are intrinsically vulnerable to oxidative stress (Jenner 2003), which constitutes a basis of 
selective degeneration of these neurons in PD brain. 
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Figure Legends 
Fig. 1  Thrombin induces dopaminergic cell death, NO production and whole tissue injury.  
(a and b) Representative photomicrographs showing TH immunohistochemistry of a slice 
cultured under control conditions (a) and a slice treated with 300 U/ml thrombin for 72 h (b).  
Scale bar, 100 μm.  (c-g) Concentration-dependent effect of thrombin on the absolute 
number of dopaminergic neurons (c), nitrite concentrations in culture medium (d), amount of 
LDH released into culture medium (e), PI uptake into slices (f) and the absolute number of 
GABAergic neurons (g).  Midbrain slice cultures were treated with thrombin at indicated 
concentrations for 72 h.  Number of slices examined for each condition is 10 - 34.  Values 
of nitrite and LDH are of five wells from five independent experiments.  * p < 0.05, *** p < 
0.001 vs. control (Cont.). 
 
Fig. 2  Time dependency of thrombin neurotoxicity.  Midbrain slice cultures were treated 
with 300 U/ml thrombin for indicated periods.  The absolute number of dopaminergic 
neurons (a), the amount of nitrite and LDH in medium (b and c, respectively), and the 
absolute number of GABAergic neurons (d) were quantified.  Number of slices examined for 
each condition is 10 - 29.  Values of nitrite and LDH are of five wells from five independent 
experiments.  * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control (Cont.). 
 
Fig. 3  iNOS-derived NO mediates thrombin cytotoxicity on dopaminergic neurons but not 
on other midbrain cells.  (a) Double immunofluorescence shows that intense iNOS 
immunoreactivities (left) are present in a subpopulation of OX42-positive microglia (right) in 
midbrain slice cultures treated for 72 h with 300 U/ml thrombin.  Arrowheads indicate 
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examples of doubly positive cells.  Scale bar, 50 μm.  (b-e) Effect of aminoguanidine on 
thrombin-induced dopaminergic cell death (b), nitrite increase (c), LDH release (d) and PI 
uptake (e).  Aminoguanidine at indicated concentrations was applied concomitantly with 300 
U/ml thrombin for 72 h.  Number of slices examined for each condition is 10 - 33.  The 
numbers of culture wells from which values of nitrite and LDH were obtained are indicated in 
parentheses.  *** p < 0.001 vs. control (Cont.); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. 
thrombin alone. 
 
Fig. 4  MAPKs are involved in thrombin-induced cell death and NO production.  Effects of 
PD98059 (a-c), SB203580 (d-f) and SP600125 (g-i) on thrombin-induced dopaminergic cell 
death (a, d, g), nitrite increase (b, e, h) and LDH release (c, f, i) are shown.  PD98059, 
SB203580 and SP600125 at indicated concentrations were applied concomitantly with 300 
U/ml thrombin for 72 h.  Number of slices examined for each condition is 9 - 46.  The 
numbers of culture wells examined for nitrite and LDH are indicated in parentheses.  ** p < 
0.01, *** p < 0.001 vs. control (Cont.); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. thrombin 
alone. 
 
Fig. 5  MAPKs are involved in thrombin-induced iNOS expression.  (a) Thrombin-induced 
changes in levels of iNOS, phospho-JNK (p-JNK), phospho-ERK (p-ERK) and phospho-p38 
(p-p38).  Slice cultures were treated with 300 U/ml thrombin for indicated periods, and 
lysates were processed for western blot analysis.  Blots of iNOS, p-JNK and p-ERK are 
shown with that of actin, a corresponding loading control.  The blot of p-p38 is paired with 
that of total p38.  (b, c) Double immunofluorescence shows that phospho-ERK (b, left) and 
 28
phospho-JNK (c, left) are present in OX42-positive microglia (right panels) in midbrain slice 
cultures treated for 1 h with 300 U/ml thrombin.  Scale bars, 50 μm.  (d) Time course of 
phosphorylation of MAPKs in response to 300 U/ml thrombin as revealed by western blot 
analysis.  Levels of phosphorylated MAPKs (p-MAPKs) were normalized by those of actin.  
n = 5 for p-ERK, n = 4 for p-JNK and n = 3 for p-p38.  (e) Time course of iNOS expression 
in response to 300 U/ml thrombin as revealed by western blot analysis.  n = 4 for each time 
point.  ** p < 0.01 vs. time 0.  (f) Effects of inhibition of MAPKs on thrombin-induced 
iNOS expression.  PD98059 (PD; 100 μM), SB203580 (SB; 30 μM) or SP600125 (SP; 30 
μM) was applied concomitantly with 300 U/ml thrombin for 72 h, and expression levels of 
iNOS protein were examined.  Expression levels were normalized by those of 
glyceraldehyde phosphate dehydrogenase (GAPDH).  A representative blot is shown above 
the graph.  n = 5.  *** p < 0.001 vs. control (Cont.); ### p < 0.001 vs. thrombin alone. 
 
Fig. 6  Depletion of microglia protects dopaminergic neurons from thrombin cytotoxicity.  
(a-d) OX42 immunohistochemistry reveals microglial population within midbrain slice 
cultures.  Compared to control cultures (a), cultures treated with 300 U/ml thrombin for 72 h 
are characterized by the presence of numerous microglia showing activated morphology (b).  
Pretreatment of slice cultures with clodronate-containing liposomes (lip.) at indicated doses 
for 24 h markedly suppressed occupancy of tissues by microglia after thrombin treatment (c, 
d).  Scale bar, 100 μm.  (e-g) Effect of clodronate-containing liposomes on 
thrombin-induced dopaminergic cell death (e), nitrite increase (f) and LDH release (g).  
Clodronate-containing liposomes were applied at indicated doses to slice cultures for 24 h, 
which was followed by treatment with 300 U/ml thrombin for 72 h.  Number of slices 
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examined for each condition is 15 - 17.  The numbers of culture wells examined for nitrite 
and LDH are indicated in parentheses.  * p < 0.05, *** p < 0.001 vs. control (Cont.); ## p < 
0.01, ### p < 0.001 vs. thrombin alone. 
 
Fig. 7  Antioxidative drugs protect dopaminergic neurons but not other cells from thrombin 
cytotoxicity.  Effects of FeTPPS (a, b) and N-acetylcysteine (c-f) on thrombin-induced 
dopaminergic cell death (a, c), nitrite increase (d), LDH release (e) and PI uptake (b, f) are 
shown.  FeTPPS and N-acetylcysteine were applied at indicated concentrations concurrently 
with 300 U/ml thrombin for 72 h.  Number of slices examined for each condition is 11 - 33 
for FeTPPS and 9 - 20 for N-acetylcysteine, respectively.  The numbers of culture wells 
examined for nitrite and LDH are indicated in parentheses.  *** p < 0.001 vs. control 
(Cont.); # p < 0.05, ### p < 0.001 vs. thrombin alone. 
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